تولید ژلاتین کپسول ایران
دکپسول | Stocks - Iran Fara Bourse (IFB)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 192,300 3.00
Close Price: 191,900
Balance Sheet
AGM
Interim
2026/06/28 Fiscal Year 2026/03/2012 Month | 2025/05/04 Fiscal Year 2025/03/2012 Month | 2024/05/05 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 1.221 Trillion | 2.137 Trillion | 687 Billion | |
Short-Term Investments | - | - | 3 Million | |
Trade Receivables | 4.189 Trillion | 2.983 Trillion | 1.823 Trillion | |
Prepayments | 4.574 Trillion | 599.321 Billion | 1.936 Trillion | |
Raw Materials & Packaging Inventory | 916.559 Billion | 1.599 Trillion | 1.015 Trillion | |
Work-in-Progress Inventory | - | 33.939 Billion | - | |
Finished Goods Inventory | 110.858 Billion | 120.722 Billion | 137.746 Billion | |
Goods in Transit | 637.222 Billion | 227.341 Billion | - | |
Other Inventories | 468.099 Billion | 398.198 Billion | 360.198 Billion | |
Inventories | 2.133 Trillion | 2.38 Trillion | 1.513 Trillion | |
Total Current Assets | 12.116 Trillion | 8.099 Trillion | 5.959 Trillion | |
Long-Term Investments | 1.166 Billion | 1.107 Billion | - | |
Long-Term Trade Receivables | 23.622 Billion | 22.927 Billion | 21.02 Billion | |
Intangible Assets | 40.637 Billion | 46.904 Billion | 20.299 Billion | |
Property, Plant & Equipment | 5.818 Trillion | 5.4 Trillion | 1.868 Trillion | |
Net Fixed Assets | 5.818 Trillion | 5.4 Trillion | 1.868 Trillion | |
Total Non-Current Assets | 5.883 Trillion | 5.471 Trillion | 1.91 Trillion | |
Total Assets | 18 Trillion | 13.57 Trillion | 7.869 Trillion | |
Trade Payables | 1.225 Trillion | 912.662 Billion | 603.881 Billion | |
Advances Received | 912.266 Billion | 861.55 Billion | 356.808 Billion | |
Income Tax Provision | 2.224 Trillion | 1.242 Trillion | 959.372 Billion | |
Other Provisions | - | - | 500 Million | |
Proposed & Payable Dividends | 36.858 Billion | 123.886 Billion | 88.525 Billion | |
Current Borrowings | 2.731 Trillion | 753.95 Billion | 1.221 Trillion | |
Total Current Liabilities | 7.13 Trillion | 3.894 Trillion | 3.23 Trillion | |
Long-Term Payables | 28.77 Billion | 22.193 Billion | 15.618 Billion | |
Long-Term Borrowings | 149.198 Billion | 211.249 Billion | 260.658 Billion | |
Employee Termination Benefits Provision | 352.796 Billion | 185.895 Billion | 126.337 Billion | |
Total Non-Current Liabilities | 530.764 Billion | 419.337 Billion | 402.613 Billion | |
Total Liabilities | 7.66 Trillion | 4.314 Trillion | 3.632 Trillion | |
Capital | 300 Billion | 300 Billion | 300 Billion | |
Retained Earnings | 6.836 Trillion | 5.796 Trillion | 3.877 Trillion | |
Legal Reserve | 30 Billion | 30 Billion | 30 Billion | |
Share Premium Reserve | 99.593 Billion | 56.779 Billion | 29.689 Billion | |
Total Equity | 10.339 Trillion | 9.256 Trillion | 4.236 Trillion | |
Total Liabilities & Equity | 18 Trillion | 13.57 Trillion | 7.869 Trillion | |
Approved Capital | 300 Billion | 300 Billion | 300 Billion | |
Approved Retained Earnings | 1.706 Trillion | 1.446 Trillion | 1.477 Trillion | |
Approved Legal Reserve | 30 Billion | 30 Billion | 30 Billion | |
Total Approved Equity (at AGM) | 2.036 Trillion | 1.776 Trillion | 1.807 Trillion | |
Revaluation Surplus of Property, Plant and Equipment | 3.074 Trillion | 3.074 Trillion | - |